NCT06732349Recruiting
Urinary Tubular Biomarkers for Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 7 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Currently used tests for chronic kidney injury only assess the function of one part of the kidney: the filter called the glomerulus. The other part, called the tubule, is disregarded. Based on many previous studies, the investigators have good reason to assume that a better prediction of the course of chronic kidney disease by testing tubular function will be possible. This is important, for example, when patients need to be treated with kidney-protecting drugs.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 556 (estimated)
- First submitted
- 10 Dec 2024
- Start date
- 1 Jan 2025
- Primary completion date
- Dec 2029
- Lead sponsor
- Erasmus Medical Center
- Diseases
- Chronic kidney disease
- NCT number
- NCT06732349
What you commit to
- Study type: Observational
- Planned participants: 556
- From 1 Jan 2025 to the primary completion date, Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Active glomerulonephritis treated with immunosuppression
- Kidney transplant recipient
- Current treatment with chemo- or immunotherapy for malignancy
Who the study is looking for
- Chronic kidney disease stage 3 (eGFR 30-59ml/min)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erasmus MC Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.